JETBLUE AIRWAYS CORP (JBLU)

US4771431016 - Common Stock

7.46  +0.05 (+0.67%)

Fundamental Rating

2

Taking everything into account, JBLU scores 2 out of 10 in our fundamental rating. JBLU was compared to 24 industry peers in the Passenger Airlines industry. Both the profitability and financial health of JBLU have multiple concerns. JBLU is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

JBLU had negative earnings in the past year.
JBLU had a positive operating cash flow in the past year.
In the past 5 years JBLU reported 4 times negative net income.
JBLU had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

JBLU has a Return On Assets of -2.24%. This is in the lower half of the industry: JBLU underperforms 62.50% of its industry peers.
JBLU has a Return On Equity (-9.29%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.24%
ROE -9.29%
ROIC N/A
ROA(3y)-2.12%
ROA(5y)-2.33%
ROE(3y)-8.06%
ROE(5y)-9.32%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

JBLU's Gross Margin of 63.58% is fine compared to the rest of the industry. JBLU outperforms 79.17% of its industry peers.
JBLU's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for JBLU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.29%

1

2. Health

2.1 Basic Checks

JBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
JBLU has more shares outstanding than it did 1 year ago.
The number of shares outstanding for JBLU has been increased compared to 5 years ago.
JBLU has a worse debt/assets ratio than last year.

2.2 Solvency

JBLU has an Altman-Z score of 0.92. This is a bad value and indicates that JBLU is not financially healthy and even has some risk of bankruptcy.
JBLU has a Altman-Z score of 0.92. This is comparable to the rest of the industry: JBLU outperforms 45.83% of its industry peers.
A Debt/Equity ratio of 1.32 is on the high side and indicates that JBLU has dependencies on debt financing.
With a Debt to Equity ratio value of 1.32, JBLU perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF N/A
Altman-Z 0.92
ROIC/WACCN/A
WACC6.89%

2.3 Liquidity

A Current Ratio of 0.60 indicates that JBLU may have some problems paying its short term obligations.
JBLU has a Current ratio of 0.60. This is comparable to the rest of the industry: JBLU outperforms 41.67% of its industry peers.
JBLU has a Quick Ratio of 0.60. This is a bad value and indicates that JBLU is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.57, JBLU perfoms like the industry average, outperforming 45.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.57

4

3. Growth

3.1 Past

JBLU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.05%, which is quite impressive.
Looking at the last year, JBLU shows a small growth in Revenue. The Revenue has grown by 5.00% in the last year.
JBLU shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.66% yearly.
EPS 1Y (TTM)44.05%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-186.36%
Revenue 1Y (TTM)5%
Revenue growth 3Y48.15%
Revenue growth 5Y4.66%
Revenue growth Q2Q-3.73%

3.2 Future

JBLU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.67% yearly.
The Revenue is expected to grow by 4.36% on average over the next years.
EPS Next Y-70.68%
EPS Next 2Y30.55%
EPS Next 3Y34.67%
EPS Next 5YN/A
Revenue Next Year-0.4%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JBLU. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JBLU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as JBLU.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.93

4.3 Compensation for Growth

JBLU's earnings are expected to grow with 34.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.55%
EPS Next 3Y34.67%

0

5. Dividend

5.1 Amount

JBLU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JETBLUE AIRWAYS CORP

NASDAQ:JBLU (3/28/2024, 1:01:06 PM)

7.46

+0.05 (+0.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.53B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.24%
ROE -9.29%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 63.58%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.6
Quick Ratio 0.57
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)44.05%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-70.68%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5%
Revenue growth 3Y48.15%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y